U.S. stocks jumped to start the week on positive coronavirus vaccine news. Meanwhile, economies around the world are slowly starting to reopen from their forced coronavirus shutdowns, and Fed Chairman Jay Powell’s 60 Minutes interview highlighted why investors are likely to remain in ‘don’t fight the Fed’ mode.
That said, stocks fell in late afternoon trading Tuesday to showcase continued market volatility. And the second quarter earnings picture looks far worse than what we have seen from Q1. Yet, Wall Street has been looking ahead to the coronavirus recovery for roughly two months now.
Therefore, it still appears to be a good time to look for some new stocks to buy or at least add to your watchlist. And today we screened for strong stocks that recently received new analyst coverage.
Broker recommendations play their part no matter how investors feel about them. And we seemingly all take a look no matter what. Individual investors, large institutional portfolio managers, and everyone in between are likely pleased to see one of their stocks get an upgraded rating or a new analyst cover the company.
New Analyst Coverage
Right off the bat, investor interest can generate more analyst coverage. This helps explain why analysts jump on young, much-hyped and talked about tech companies. Then, as new coverage is initiated, the company and the stock become more visible, which in turn often leads to more demand potential and therefore the possibility of higher prices.
Plus, analysts almost always initiate coverage with a positive recommendation. And the logic follows because why spend all the time and write a research report on a company not widely tracked only to say it’s not good?
When it comes to companies with little to no analyst coverage, one new recommendation can sometimes give portfolio managers the validation they need to build a position. And the more money they can invest, the more they can potentially influence prices.
The best way to use this information is to search for companies with analyst coverage that has increased over the last 4 weeks. We just look at the number of analyst recommendations today and compare it to the number of analyst recommendations 4 weeks ago.
The rule of thumb here is that an increase in coverage leans bullish and a decrease signals bearish behavior. It is also worth pointing out that, in general, the change in the average broker recommendation is a better indicator than the actual recommendation itself.
On top of that, it is typically more bullish if the increase went from none to one or if the coverage was minimal to begin with. (As the number of analysts climbs the addition of new coverage isn’t earth-shattering.) In the end, increased coverage is still better than decreased coverage, unless the coverage is heading in the wrong direction.
Now let’s try this screen…
• Number of Broker Ratings now greater than the Number of Broker Ratings four weeks ago
(This shows stocks where new coverage has recently been added.)
• Average Broker Rating less than Average Broker Rating four weeks ago
(By 'less than', we mean 'better than' four weeks ago.)
• Prices greater than or equal to 5
(We’re applying all of the above parameters to stocks above $5 a share since many money managers won't even look at stocks under $5)
• Average Daily Volume greater than or equal to 100,000 shares
(If there's not enough volume, even individual investors won't want it).
Here are 3 of the 8 stocks that came through the screen this week…
Sequans Communications S.A. (SQNS) - (from 2 analysts four weeks ago to 4)
VeriSign (NASDAQ:VRSN), Inc. (VRSN) - (from 2 analysts four weeks ago to 3)
Aeglea BioTherapeutics, Inc. (AGLE) - (from 2 analysts four weeks ago to 4)
Many screeners won't let you search for the number of analysts covering a stock, let alone comparing the amount of coverage they had weeks or even months ago. But you can with the Research Wizard. And you can backtest it all. Find out how to pick the right stocks right now by taking a free trial to the Research Wizard stock picking and backtesting program.
Click here to sign up for a free trial to the Research Wizard today.
Want more articles from this author? Scroll up to the top of this article and click the FOLLOW AUTHOR button to get an email each time a new article is published.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.
Today's Stocks from Zacks' Best Screens
Now would you like to screen for the latest stocks from Zacks' most successful strategies? From 2017 through Q3 2019, while the market gained +39.6%, we saw results like these: Big Money Zacks +57.5%, Small-Cap Growth +43.1%,Technical Analysis & Fundamental Analysis +96.9%, New Highs +119.0%, and Filtered Zacks Rank 5 +158.9%.
You're invited to screen the latest stocks in seconds by trying Zacks' Research Wizard stock-picking program. Or use the Wizard to create your own market-beating strategies. No credit card needed, no cost or obligation.
Try it for 2 weeks free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
VeriSign, Inc. (VRSN): Free Stock Analysis Report
Sequans Communications S.A. (SQNS): Free Stock Analysis Report
Aeglea BioTherapeutics, Inc. (AGLE): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research